Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
This study has been terminated.
(low enrollment)
Sponsor:
Eastern Virginia Medical School
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Eastern Virginia Medical School
ClinicalTrials.gov Identifier:
NCT00493896
First received: June 27, 2007
Last updated: September 27, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2010 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |